IMUX

Conviction 100HealthcareScan · Mon, Jul 20, 2026

IMUX$15.04-0.79%

ResistanceSupportVol 14

Vol MA14 184.32K

Apr 20May 6May 26Jun 11Jul 1Jul 20

IMMUNIC, INC.PHARMACEUTICAL PREPARATIONSwww.imux.com ↗

Price15.04

Change-0.79%

Gap+0.26%

Rel volume2.58×

Avg volume203.95K

Avg $ vol3.06M

SMA 2014.97

SMA 5013.83

SMA 2004.47

Price vs 50+8.71%

Price vs 200+236.24%

MA stackbullish

50/200 cross—

Supertrendup · 12.65

RSI (14)59

MACD hist-0.12

MACD cross—

Stoch %K / %D53 / 55

ADX (14)33

+DI / −DI20 / 10

RSI divergence—

MACD divergence—

ATR %+6.24%

ADR %5.96%

52w high15.41

52w low0.5102

From 52w high-2.40%

Above 52w low+2847.86%

New 52w highNo

SqueezeOn · 7d

Bollinger width6.49%

%B0.57

Donchian pos53.49%

Donchian high15.84

Donchian low14.12

AVWAP (52w high)15.08

vs AVWAP high-0.26%

AVWAP (52w low)1.59

vs AVWAP low+843.73%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d2.58×

Avg vol (14d)184.32K

Avg vol (20d)203.95K

Avg $ vol (20d)3.06M

Market cap204.87M

RS 3m (vs SPY)+1410.07%

RS 6m (vs SPY)+2224.64%

RS line new highNo

Trend template8/8

Technical rank92.1

1 week+2.73%

1 month+5.92%

3 months+1404.00%

6 months+2254.05%

1 year+1517.20%

YTD+2479.76%

P/E-2.11

P/B1.35

P/S—

P/FCF-2.38

EPS-0.6200

Div yield—

ROE-64.25%

ROA-51.21%

Debt/Eq—

Current4.92

EV/EBITDA-0.18

Gross margin—

Net margin—

Rev growth—

EPS growth3.32%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value18.24M

Revenue22K

Net income-32.59M

Gross profit9K

Free cash flow-85.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees95

ListedThu, Apr 17, 2014

Free float120.71M

Float %88.6%

Short interest1.59M

Days to cover7.5d

Short volume43.8%

Squeeze score45 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank92.1 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.76

Support11.82

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMUX

All disclosures →

No recent disclosed trades by Congress in IMUX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMUX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Congleton Jon Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Rudick Richard Alan Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Neermann Joerg Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Skerjanec Simona Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
PHILLIPS BARCLAY A Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Congleton Jon Director · Stock Option · 2026-06-29	Grant	50.74K	—	2026-06-29	2026-06-29
HOWSON TAMAR D Director · Stock Option · 2026-06-29	Grant	25.37K	—	2026-06-29	2026-06-29
BONNEY MICHAEL W Director · Stock Option · 2026-06-29	Grant	100K	—	2026-06-29	2026-06-29
Vitt Daniel Director · Stock Option · 2026-06-29	Grant	445K	—	2026-06-29	2026-06-29
Whaley Glenn Chief Financial Officer · Stock Option · 2026-06-29	Grant	120K	—	2026-06-29	2026-06-29

SEC filings

EDGAR filings in IMUX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.